» Articles » PMID: 28212850

Human Astrocytes in the Diseased Brain

Overview
Journal Brain Res Bull
Specialty Neurology
Date 2017 Feb 19
PMID 28212850
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes are key active elements of the brain that contribute to information processing. They not only provide neurons with metabolic and structural support, but also regulate neurogenesis and brain wiring. Furthermore, astrocytes modulate synaptic activity and plasticity in part by controlling the extracellular space volume, as well as ion and neurotransmitter homeostasis. These findings, together with the discovery that human astrocytes display contrasting characteristics with their rodent counterparts, point to a role for astrocytes in higher cognitive functions. Dysfunction of astrocytes can thereby induce major alterations in neuronal functions, contributing to the pathogenesis of several brain disorders. In this review we summarize the current knowledge on the structural and functional alterations occurring in astrocytes from the human brain in pathological conditions such as epilepsy, primary tumours, Alzheimer's disease, major depressive disorder and Down syndrome. Compelling evidence thus shows that dysregulations of astrocyte functions and interplay with neurons contribute to the development and progression of various neurological diseases. Targeting astrocytes is thus a promising alternative approach that could contribute to the development of novel and effective therapies to treat brain disorders.

Citing Articles

Brain Glycogen-Its Metabolic Role in Neuronal Health and Neurological Disorders-An Extensive Narrative Review.

Beltran-Velasco A Metabolites. 2025; 15(2).

PMID: 39997753 PMC: 11857135. DOI: 10.3390/metabo15020128.


Reprogramming astrocytes into dopaminergic neurons to restore motor dysfunction in Parkinsons disease model rats.

Liu C, Ying M, Wang A, Liu Y, Chen Y, Ye W Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(9):1377-1389.

PMID: 39931768 PMC: 11814384. DOI: 10.11817/j.issn.1672-7347.2024.240078.


The mTOR Pathway: A Common Link Between Alzheimer's Disease and Down Syndrome.

Wohlfert A, Phares J, Granholm A J Clin Med. 2024; 13(20).

PMID: 39458132 PMC: 11508835. DOI: 10.3390/jcm13206183.


Astrocyte-Mediated Neuroinflammation in Neurological Conditions.

Zhao Y, Huang Y, Cao Y, Yang J Biomolecules. 2024; 14(10).

PMID: 39456137 PMC: 11505625. DOI: 10.3390/biom14101204.


Targeting the neurovascular unit: Therapeutic potential of traditional Chinese medicine for the treatment of stroke.

Wu B, Zhou D, Mei Z Heliyon. 2024; 10(19):e38200.

PMID: 39386825 PMC: 11462356. DOI: 10.1016/j.heliyon.2024.e38200.


References
1.
Malkesman O, Austin D, Tragon T, Wang G, Rompala G, Hamidi A . Acute D-serine treatment produces antidepressant-like effects in rodents. Int J Neuropsychopharmacol. 2011; 15(8):1135-48. PMC: 3278496. DOI: 10.1017/S1461145711001386. View

2.
Kanaumi T, Milenkovic I, Adle-Biassette H, Aronica E, Kovacs G . Non-neuronal cell responses differ between normal and Down syndrome developing brains. Int J Dev Neurosci. 2013; 31(8):796-803. DOI: 10.1016/j.ijdevneu.2013.09.011. View

3.
Lyons S, Chung W, Weaver A, Ogunrinu T, Sontheimer H . Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res. 2007; 67(19):9463-71. PMC: 2045073. DOI: 10.1158/0008-5472.CAN-07-2034. View

4.
Querfurth H, LaFerla F . Alzheimer's disease. N Engl J Med. 2010; 362(4):329-44. DOI: 10.1056/NEJMra0909142. View

5.
Richerson G, Wu Y . Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore. J Neurophysiol. 2003; 90(3):1363-74. DOI: 10.1152/jn.00317.2003. View